Today: 20 July 2026
Browse Category

NASDAQ:CYPH 12 November 2025 - 10 December 2025

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies Inc. has stormed into the spotlight after a radical pivot from small‑cap biotech to what is effectively a listed Zcash treasury vehicle backed by the Winklevoss twins. The stock has been halted, squeezed, sold by insiders, loved by day‑traders and treated with caution by Wall Street — all in under a month.
Biggest Stock Gainers Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and DBI Lead the After‑Bell Rally

Biggest Stock Gainers Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and DBI Lead the After‑Bell Rally

U.S. stocks ended Tuesday’s session mostly flat ahead of the Federal Reserve’s final policy decision of 2025, but under the surface the tape was anything but quiet. While the S&P 500 slipped roughly 0.02%, the Dow fell about 0.32% and the Nasdaq 100 edged up around 0.18%, a pack of small‑ and mid‑cap names posted spectacular double‑ and triple‑digit gains. StockAnalysis+1
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

CYPH Debuts: Cypherpunk Technologies (ex‑Leap Therapeutics) starts trading, files $200M ATM, posts Q3 results and details $50M Zcash treasury — 13 Nov 2025

Cypherpunk Technologies Inc. — the newly renamed Leap Therapeutics — began trading on the Nasdaq this morning under the ticker CYPH, marking the company’s formal pivot from oncology biotech to a “digital‑asset treasury” strategy centered on Zcash. Options symbols and identifiers also updated in step with the change. PR Newswire+1
Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)

Leap Therapeutics, Inc. unveiled a sweeping strategic pivot today: the oncology company is rebranding as Cypherpunk Technologies Inc., has already purchased ~$50 million of Zcash for a new digital‑asset treasury strategy, and will switch its Nasdaq ticker from LPTX to CYPH at the open on Thursday, Nov. 13, 2025. The company also filed fresh SEC documents, including Q3 2025 results and a $200 million at‑the‑market equity program with Cantor Fitzgerald. PR Newswire+2SEC+2
Go toTop